A novel member of the IB family, human IB-, was identified by a differential screening approach of apoptosis-sensitive and -resistant tumor cells. The protein consists of 6 ankyrin repeats at its COOH terminus and shares about 30% identity with other IB members. IB-associates with both the p65 and p50 subunit of NF-B and inhibits the transcriptional activity as well as the DNA binding of the transcription factor. Interestingly, IB-is localized in the nucleus where it aggregates in matrix-associated deacetylase bodies, indicating that IB-regulates nuclear NF-B activity rather than its nuclear translocation from the cytoplasm. IBexpression itself was regulated by NF-B, suggesting that its activity is controlled in a negative feedback loop. Unlike classical IB proteins, IB-was not degraded upon cell stimulation. Treatment with tumor necrosis factor-␣, interleukin-1, and lipopolysaccharide induced a strong induction of IB-transcripts. Expression of IB-was detected in different tissues including lung, liver, and in leukocytes but not in the brain. Suppression of endogenous IB-by RNA interference rendered cells more resistant to apoptosis, whereas overexpression of IB-was sufficient to induce cell death. Our results, therefore, suggest that IB-functions as an additional regulator of NF-B activity and, hence, provides another control level for the activation of NF-B-dependent target genes.NF-B is an evolutionarily conserved pleiotropic transcription factor that plays a crucial role in many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis, and apoptosis (Refs. 2-6; for review, see Ref. 1). The mammalian NF-B/Rel family consists of RelA (p65), RelB, c-Rel, p50, and p52 that bind as homo-or heterodimers at B sites in the DNA of their target genes. This combinatorial diversity contributes to the regulation of a distinct but overlapping set of genes, in that the individual dimers have distinct preferences for different B sites that they can bind with distinguishable affinity and specificity. In addition, whether the transcription of a target gene is activated or repressed depends on the dimer combination. While RelA/ p50, RelA/c-Rel, RelB/p50, and RelB/p52 heterodimers are transcriptional activators, p50/p50 and p52/p52 homodimers generally repress transcription (7-9). Regulation of the great diversity of genes requires a precise control of NF-B, which is achieved by various mechanisms of posttranslational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. Dysregulation of NF-B activation results in a wide range of human disorders including inflammatory and neurodegenerative diseases (10, 11) and different types of cancer (4, 12).NF-B activity is also tightly regulated by interaction with IB proteins (13). Characteristic for all IB proteins is a domain of multiple ankyrin repeats that bind to the conserved Rel homology domain of NF-B proteins. Various members of the IB family target different NF-B complexes, e.g....